Cargando…
Treatment of actinic keratosis through inhibition of cyclooxygenase‐2: Potential mechanism of action of diclofenac sodium 3% in hyaluronic acid 2.5%
Cyclooxygenase‐2 (COX‐2) and its metabolic product prostaglandin E(2) (PGE(2)) are induced in response to growth factors, inflammatory cytokines, tumor promoters, activated oncogenes, and, in the skin, ultraviolet (UV) radiation. Accumulating evidence suggests a role for the COX‐2/PGE(2) pathway in...
Autores principales: | Thomas, Gareth J., Herranz, Pedro, Cruz, Susana Balta, Parodi, Aurora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767532/ https://www.ncbi.nlm.nih.gov/pubmed/30523664 http://dx.doi.org/10.1111/dth.12800 |
Ejemplares similares
-
Cyclooxygenase-2 expression in actinic keratosis
por: Adamska, Kinga, et al.
Publicado: (2018) -
Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis
por: Thomas, Gareth J., et al.
Publicado: (2017) -
Comparative study of actinic keratosis treatment with 3% diclofenac
sodium and 5% 5-fluorouracil()
por: Segatto, Majoriê Mergen, et al.
Publicado: (2013) -
Topical Diclofenac Reprograms Metabolism and Immune Cell Infiltration in Actinic Keratosis
por: Singer, Katrin, et al.
Publicado: (2019) -
Diclofenac-Derived Hybrids for Treatment of Actinic Keratosis and Squamous Cell Carcinoma
por: Tampucci, Silvia, et al.
Publicado: (2019)